Literature DB >> 27862711

Thalidomide for steroid-dependent chronic disseminated candidiasis after stem cell transplantation: A case report.

Blandine Rammaert1, Sophie Candon2,3, Christophe Maunoury4, Marie-Elisabeth Bougnoux3,5, Grégory Jouvion3,6, Thorsten Braun7, Jean-Michel Correas8, Olivier Lortholary1,3,9,10.   

Abstract

Chronic disseminated candidiasis (CDC) is a rare and difficult-to-treat invasive fungal disease occurring mainly after prolonged and profound neutropenia. We describe the case of a 59-year-old man successfully treated with thalidomide for CDC recurrences after an autologous transplantation. We add evidence of the effectiveness of immunomodulatory drugs to manage inflammatory reconstitution immune syndrome-related refractory CDC.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Candidazzm321990; chronic disseminated candidiasis; immune reconstitution inflammatory syndrome; stem cell transplantation

Mesh：

Substances：

Year:  2016        PMID： 27862711     DOI： 10.1111/tid.12637

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN： 1398-2273            Impact factor:   2.228


  1 in total

1.  Case Report: Immune reconstitution inflammatory syndrome after hematopoietic stem cell transplantation for severe combined immunodeficiency.

Authors:  Shuangjun Liu; Feng Huo; Guorui Dai; Jie Wu; Maoquan Qin; Huawei Mao; Quan Wang
Journal:  Front Immunol       Date:  2022-09-26       Impact factor: 8.786
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.